Astrana Health, Inc. (ASTH)

Nasdaq Health Care Health Care Facilities S&P SmallCap 600
$34.50
-4.51 (-11.56%)
Close of Nov 06, 2026 · end-of-day data
Source: Astrana Health, Inc.'s 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2017FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$57.43M$356.36M$519.91M$560.62M$687.18M$773.91M$1.14B$1.39B$2.03B$3.18B
Cost of revenue—$273.45M$361.13M$467.81M$539.21M$596.14M$944.68M$1.17B$1.76B$2.84B
Gross profit—$82.90M$158.78M$92.81M$147.97M$177.77M$199.48M$214.96M$271.39M$341.53M
Operating income-$10.54M$35.15M$88.43M$32.42M$80.50M$98.18M$104.27M$84.61M$89.35M$78.53M
Interest expense$82.91K$79.69K$561.00K$4.73M$9.50M$5.39M$7.92M$16.10M$33.10M$49.93M
Pre-tax income-$8.73M$49.71M$82.63M$25.84M$178.43M$77.75M$86.62M$89.84M$80.82M$39.61M
Income tax-$47.49K$3.89M$22.36M$8.17M$56.34M$31.69M$40.88M$31.99M$30.89M$15.53M
Net income-$8.97M$25.80M$10.84M$14.12M$37.69M$68.92M$45.17M$60.72M$43.15M$22.49M
EBITDA-$9.89M$54.22M$107.73M$50.70M$98.85M$115.70M$121.81M$102.36M$117.28M$124.27M
EPS (basic)$-1.49$1.01$0.33$0.41$1.03$1.57$1.00$1.30$0.91$0.46
EPS (diluted)$-1.49$0.90$0.29$0.39$1.01$1.52$0.99$1.29$0.90$0.46
Diluted shares6.00M28.66M37.91M36.40M37.45M45.40M45.60M46.94M47.97M49.37M
Gross margin—23.3%30.5%16.6%21.5%23.0%17.4%15.5%13.3%10.7%
Operating margin-18.3%9.9%17.0%5.8%11.7%12.7%9.1%6.1%4.4%2.5%
Net margin-15.6%7.2%2.1%2.5%5.5%8.9%3.9%4.4%2.1%0.7%

Balance sheet

fiscal years · USD
Fiscal yearFY2017FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$63.25M$99.75M$106.89M$103.19M$193.47M$233.10M$288.03M$293.81M$288.45M$429.47M
Short-term investments—$1.14M$1.13M$116.54M$67.69M$53.42M$5.57M$2.50M$2.38M—
Receivables$5.51M$7.60M$7.73M$11.00M$7.06M$10.61M$49.63M—$275.99M$374.46M
Total current assets$14.92M$144.16M$172.86M$329.07M$338.58M$404.46M$428.12M$461.51M$638.50M$863.31M
Goodwill$1.62M$189.85M$185.81M$238.50M$232.43M$246.42M$269.05M$278.83M$419.25M$865.30M
Total assets$20.64M$490.64M$513.00M$728.71M$817.49M$867.36M$966.21M$933.36M$1.35B$2.22B
Total current liabilities$14.54M$109.60M$72.02M$105.42M$114.99M$114.72M$148.61M$218.67M$365.61M$615.27M
Short-term debt$9.90M—$0$9.50M$10.89M$780.00K$619.00K$19.50M$9.38M$47.87M
Long-term debt——$0$232.17M$230.21M$182.92M$203.39M$258.94M$425.30M$990.90M
Total debt$9.90M—$0$241.67M$241.10M$183.70M$204.01M$278.44M$434.67M$1.04B
Total liabilities$20.37M$154.32M$106.34M$367.65M$372.34M$356.72M$407.67M$522.59M$840.73M$1.66B
Shareholders' equity-$353.88K$159.95M$180.55M$191.55M$330.82M$448.17M$542.56M$614.22M$712.72M$779.29M

Cash flow

fiscal years · USD
Fiscal yearFY2017FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow-$8.14M$51.83M$25.50M$13.67M$46.16M$70.33M$82.13M$68.23M$52.20M$114.60M
Capital expenditures$297.56K$2.08M$1.17M$1.04M$1.16M$19.22M$22.94M$28.53M$8.03M$10.11M
Free cash flow-$8.44M$49.75M$24.33M$12.63M$45.00M$51.11M$59.19M$39.70M$44.17M$104.49M
Investing cash flow-$1.39M$26.72M-$25.18M-$180.63M$95.49M$16.54M-$7.11M-$65.52M-$192.40M-$539.00M
Financing cash flow$8.92M-$14.98M-$11.18M$163.33M-$51.70M-$47.75M-$20.09M$3.42M$135.15M$569.35M
Dividends paid—$10.45M$17.76M$61.72M$51.32M$31.09M$14.03M$62.07M$4.04M$7.88M
Share buybacks—$3.18M$5.05M$7.57M$537.00K$5.74M$9.25M$10.19M$900.00K$25.60M
Stock-based compensation$1.11M$2.74M$1.44M$1.55M$3.38M$6.75M$16.10M$22.04M$34.54M$38.60M
Depreciation & amortization$645.74K$19.08M$19.30M$18.28M$18.35M$17.52M$17.54M$17.75M$27.93M$45.75M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.